#16,727
While it's true that somewhere between 98%-99% of those infected with COVID-19 survive their illness, we continue to see disturbing data suggesting that many survivors come away with lingering - sometimes permanent - sequelae.
Dubbed `Long COVID' or `Post-COVID Syndrome', these persistent after-effects can range from mild or moderate - to disabling - and may potentially contribute to an early death months or years after the the initial infection.
Slide From June 17th, 2021 CDC COCA Call on `Post-COVID' Syndrome
While fatigue and anosmia are probably the most common complaints, `brain fog' and other `cognitive' deficits rank high on the list of symptoms (see CMAJ: Even Mild COVID-19 May Have Long-term Brain Impacts).Viral epidemics and pandemics have a history of leaving behind poorly understood `post-pandemic' illnesses, often involving neurological manifestations. ME/CFS is an apparent post-viral syndrome - that once ignored - is now taken very seriously by the National Institute of Health.
In the ten years following the 1918 H1N1 pandemic, the world saw a mysterious global epidemic of Encephalitis Lethargica (The Lancet: COVID-19: Can We Learn From Encephalitis Lethargica?). Among those who survived, Parkinsonism and other neurological sequelae were common.
While many continue to maintain that COVID infection is `no worse than the flu', the long-term impacts of this Coronavirus pandemic - both on individual health and on society - may not become fully evident for years.
On Thursday of this week, the CDC will hold a COCA call for clinicians on dealing with patients presenting with cognitive deficits following COVID infection. These presentations are often technical, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to the general public.
As always, If you are unable to attend the live presentation, these (and past) webinars are archived and available for later viewing at this LINK.
Details on this week's presentation follows:
Overview
During this COCA Call, presenters will discuss post-COVID conditions (PCC), an umbrella term for the wide range of health consequences that are present four or more weeks after infection with SARS-CoV-2, which includes long COVID. Cognitive symptoms, often described by patients as “brain fog”, are frequently reported following SARS-CoV-2 infection. The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has recently published a Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Cognitive Symptoms in PCC that provides practical guidance to clinicians in the assessment and treatment of individuals with cognitive symptoms and a history consistent with PCC. The burden of PCC is expected to reflect the disproportionate burden of infection by race, ethnicity, and socioeconomic status and to highlight ongoing inequities in health care. The Health Equity Work Group of the AAPM&R has developed guidance to highlight the central role that principles of diversity, equity, and inclusion play in delivering quality health care.
Presenters
Jennifer Cope, MD, MPH
Medical Officer
Post-COVID Conditions Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Michelle Haddad, PhD
Director of Post-COVID Neuropsychology Clinic
Director of Inpatient Neuropsychology
Departments of Rehabilitation Medicine & Neurology
Emory University School of Medicine
Jeffrey S. Fine, MD, FAAPMR
Associate Professor and Vice Chair, Rusk Rehabilitation
Dept of Rehabilitation Medicine and Dept of Medicine
NYU Langone Health
Talya K. Fleming, MD
Assistant Professor and Medical Director
JFK Johnson Rehabilitation Institute
Dept of Physical Medicine and Rehabilitation
Hackensack Meridian Medicine
Call Materials
None at this time
Call Details
When:
Thursday, May 5, 2022,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1603316732
Passcode: 828356
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590
International numbers
One-tap mobile:
US: +16692545252,,1603316732#,,,,*828356# or +16468287666,,1603316732#,,,,*828356#
Webinar ID: 828356
